Lingzhi Wu

1.6k total citations
62 papers, 1.0k citations indexed

About

Lingzhi Wu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Nephrology. According to data from OpenAlex, Lingzhi Wu has authored 62 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Nephrology. Recurrent topics in Lingzhi Wu's work include Anesthesia and Neurotoxicity Research (6 papers), Ubiquitin and proteasome pathways (5 papers) and Additive Manufacturing Materials and Processes (5 papers). Lingzhi Wu is often cited by papers focused on Anesthesia and Neurotoxicity Research (6 papers), Ubiquitin and proteasome pathways (5 papers) and Additive Manufacturing Materials and Processes (5 papers). Lingzhi Wu collaborates with scholars based in China, United Kingdom and United States. Lingzhi Wu's co-authors include Daqing Ma, Hailin Zhao, Hao Weng, Azeem Alam, Cui Jiang, Dong‐Xin Wang, Dong-Liang Mu, Wenwen Zhang, Shiori Eguchi and Shuan Dong and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and FEBS Letters.

In The Last Decade

Lingzhi Wu

56 papers receiving 995 citations

Peers

Lingzhi Wu

IMMUN

PMH

PRM

Jianteng Gu China

Ellen Bennett United States

Liu‐Lin Xiong China

Shuai Miao China

Marlene Tschernatsch Germany

Il-Woo Shin South Korea

Juha Koskenvuo Finland

Tobias Piegeler Switzerland

Jianguo Xu China

Jianteng Gu China

Lingzhi Wu

360 ×1.0

274 ×1.7

146 ×0.9

IMMUN

40 ×0.3

PMH

161 ×1.1

PRM

Citations per year, relative to Lingzhi Wu Lingzhi Wu (= 1×) peers Jianteng Gu

Countries citing papers authored by Lingzhi Wu

Since Specialization

Citations

This map shows the geographic impact of Lingzhi Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingzhi Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingzhi Wu more than expected).

Fields of papers citing papers by Lingzhi Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingzhi Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingzhi Wu. The network helps show where Lingzhi Wu may publish in the future.

Co-authorship network of co-authors of Lingzhi Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Lingzhi Wu. A scholar is included among the top collaborators of Lingzhi Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingzhi Wu. Lingzhi Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Lingzhi, Mengjiao Cai, Xiang Shen, et al.. (2025). USP25 maintains KRAS expression and inhibiting the deubiquitinase suppresses KRAS signaling in human cancer. Journal of Biological Chemistry. 301(7). 110337–110337.

Wang, Xinyao, et al.. (2025). Bigels as capsaicin and gallic acid co‐delivery systems: Controlled release and enhanced bioavailability. Journal of Food Science. 90(3). e70147–e70147.

Li, Jiangjiang, et al.. (2025). Targeting IDH2 promotes antitumor immunity through epigenetic activation of cGAS-STING pathway. Lung Cancer. 205. 108611–108611.

Wu, Lingzhi, Cong Zhang, Xue Jiang, et al.. (2024). Optimizing additive manufacturing parameters for martensitic stainless steel via machine learning. Materials Today Communications. 41. 110290–110290. 3 indexed citations

Bai, Xupeng, Jiarui Liu, Yingtang Zhou, et al.. (2024). METTL14 suppresses the expression of YAP1 and the stemness of triple-negative breast cancer. Journal of Experimental & Clinical Cancer Research. 43(1). 307–307. 7 indexed citations

Xu, Li, Li-Zhen Li, Lingzhi Wu, Peng Li, & Feng‐Jung Chen. (2024). CIDE proteins and their regulatory mechanisms in lipid droplet fusion and growth. FEBS Letters. 598(10). 1154–1169. 15 indexed citations

Chen, Jiaqing, et al.. (2024). A Sustainable Model for Forecasting Carbon Emission Trading Prices. Sustainability. 16(19). 8324–8324. 2 indexed citations

Wu, Lingzhi, et al.. (2024). Regulated cell death in hypoxic-ischaemic encephalopathy: recent development and mechanistic overview. Cell Death Discovery. 10(1). 277–277. 12 indexed citations

Chen, Qian, Jiashi Sun, Xiangfeng Liu, et al.. (2024). Dexmedetomidine and argon in combination against ferroptosis through tackling TXNIP-mediated oxidative stress in DCD porcine livers. Cell Death Discovery. 10(1). 319–319. 2 indexed citations

10.

Wu, Lingzhi, Dil Faraz Khan, Cong Zhang, et al.. (2023). Microstructure and mechanical characterization of additively manufactured Fe11Cr8Ni5Co3Mo martensitic stainless steel. Materials Characterization. 203. 113106–113106. 16 indexed citations

11.

Wang, Zhen, Lingzhi Wu, & Wei Wang. (2023). Innovative delivery systems for epicutaneous immunotherapy. Frontiers in Immunology. 14. 1238022–1238022. 3 indexed citations

12.

Saito, Junichi, Lingzhi Wu, Masae Iwasaki, et al.. (2023). “Anti-cancer” effect of ketamine in comparison with MK801 on neuroglioma and lung cancer cells. European Journal of Pharmacology. 945. 175580–175580. 13 indexed citations

13.

Iwasaki, Masae, Hailin Zhao, Cong Hu, et al.. (2022). The differential cancer growth associated with anaesthetics in a cancer xenograft model of mice: mechanisms and implications of postoperative cancer recurrence. Cell Biology and Toxicology. 39(4). 1561–1575. 5 indexed citations

14.

Wu, Lingzhi, Di Liu, Ming Xia, et al.. (2021). Immunofluorescence deposits in the mesangial area and glomerular capillary loops did not affect the prognosis of immunoglobulin a nephropathy except C1q:a single-center retrospective study. BMC Nephrology. 22(1). 43–43. 11 indexed citations

15.

Wang, Jiewei, Yiping Dong, Lingzhi Wu, et al.. (2021). The deubiquitinase USP28 stabilizes the expression of RecQ family helicases and maintains the viability of triple negative breast cancer cells. Journal of Biological Chemistry. 298(1). 101443–101443. 9 indexed citations

16.

Chen, Junjie, Lin Wang, Zheng Zhu, et al.. (2021). TCGA database analysis of the tumor mutation burden and its clinical significance in colon cancer. Journal of Gastrointestinal Oncology. 12(5). 2244–2259. 7 indexed citations

17.

Zhao, Hailin, Lingzhi Wu, Azeem Alam, et al.. (2020). The Role of Neutrophil NETosis in Organ Injury: Novel Inflammatory Cell Death Mechanisms. Inflammation. 43(6). 2021–2032. 84 indexed citations

18.

Zhao, Hailin, Dong-Liang Mu, Wenwen Zhang, et al.. (2019). Dexmedetomidine inhibits astrocyte pyroptosis and subsequently protects the brain in in vitro and in vivo models of sepsis. Cell Death and Disease. 10(3). 167–167. 136 indexed citations

19.

Cai, Mengjiao, Xin Liang, Huan Chen, et al.. (2019). Nuclear Receptor Coactivator 2 Promotes Human Breast Cancer Cell Growth by Positively Regulating the MAPK/ERK Pathway. Frontiers in Oncology. 9. 164–164. 21 indexed citations

20.

Wu, Lingzhi, Hailin Zhao, Tianlong Wang, Chen Pac-Soo, & Daqing Ma. (2014). Cellular signaling pathways and molecular mechanisms involving inhalational anesthetics-induced organoprotection. Journal of Anesthesia. 28(5). 740–758. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact